10.1016/j.phrs.2016.09.006 41 ZhouM.LinB
These findings offer reassurance that GLP-1 receptor agonists are not only safe for stable patients with HFrEF but may even be helpful in improving long-term clinical outcomes, says study co-author Gautam Shah, MD, a Cleveland Clinic staff cardiologist
Grether-Beck S, Marini A, Jaenicke T, Stahl W, Krutmann J
Official policies and live checkout remain controlling
Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals Judy Ly, Minette Lagman, Tommy Saing, Manpreet Kaur Singh, Enrique Vera Tudela, Devin Morris, Jessica Anderson, John Daliva, Cesar Ochoa, Nishita Patel, Daniel Pearce, Vishwanath Venketaraman Published July, 2015 in the Journal of Interferon & Cytokine Research Furthermore, we demonstrate that supplementing individuals with HIV infection for 13 weeks with liposomal GSH (lGSH) resulted in a significant increase in the levels of TH1 cytokines, IL-1, IL-12, IFN-, and TNF-